Literature DB >> 1477188

Tracer kinetic evidence for abnormal methyl metabolism in schizophrenia.

T Sargent1, N Kusubov, S E Taylor, T F Budinger.   

Abstract

The original transmethylation hypothesis of schizophrenia has evolved with time and experiment to the present concept that a defect in the methyl-carbon metabolic pathway may be causative in this illness. Various researchers have proposed that specific steps in the methyl-carbon pathway may be defective, and have presented evidence to support these possibilities. We have tested the general concept of the hypothesis by administering methionine labeled with 11C or 14C in the S-methyl carbon to patients with schizophrenia and to controls and measured the expiration of 11CO2 and 14CO2. We found that the rate and total expiration of labeled CO2 were three times less in the patients than in the controls, with no overlap of data points in the two groups. Specific steps in the methylcarbon pathway that might be defective and produce the results seen here are discussed in light of this and other researchers' findings.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1477188     DOI: 10.1016/0006-3223(92)90188-6

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  4 in total

1.  Homocysteinemia is a common feature of schizophrenia.

Authors:  B Regland; B V Johansson; B Grenfeldt; L T Hjelmgren; M Medhus
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis.

Authors:  B Regland; T Germgård; C G Gottfries; B Grenfeldt; A C Koch-Schmidt
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 3.  Endogenous neurotoxins relevant to schizophrenia.

Authors:  J Smythies
Journal:  J R Soc Med       Date:  1996-12       Impact factor: 18.000

Review 4.  The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.

Authors:  T Bottiglieri; K Hyland; E H Reynolds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.